Showing 20,321 - 20,340 results of 20,793 for search '"Therapy"', query time: 0.15s Refine Results
  1. 20321

    Self-managed physical activity in cancer survivors for the management of cancer-related fatigue: A scoping review. by Isabella Campanini, Maria Bernadette Ligabue, Maria Chiara Bò, Maria Chiara Bassi, Mirco Lusuardi, Andrea Merlo

    Published 2022-01-01
    “…Articles dealing with entirely supervised interventions, dietary or psychological-only therapies, and with palliative care were excluded.<h4>Results</h4>Of the 543 experimental or observational studies screened, 63 were included. …”
    Get full text
    Article
  2. 20322

    Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway by Ying Li, Yanying Xiong, Huihui Li, Yan Luo, Ling Zhang, Qin Zhang, Weijian Xiong, Haitao Tu

    Published 2022-01-01
    “…Taken together, rhALR could regulate the TLR4 signaling pathway to relieve inflammatory response, thereby protecting renal I/R injury, indicating that ALR is likely to be introduced to develop novel immune therapies for renal I/R injury.…”
    Get full text
    Article
  3. 20323

    Sarcopenia and frailty as predictor of outcome in critically ill elderly patients with multiple comorbidities by Dina mostafa Elmaleh, Dina Morsy Ahmed Mohamed

    Published 2025-01-01
    “…By providing appropriate therapies, medical professionals in intensive care units may be able to improve patient outcomes. …”
    Get full text
    Article
  4. 20324

    Graves’ ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions – a systematic review by Maralyn Druce, Ejaz Ansari, Oyinlola Maria Bello

    Published 2024-05-01
    “…However, available literature demonstrates that not all clinically effective treatment options improve patients’ QoL.Methods A systematic literature review was conducted to assess the clinical and psychosocial outcomes of different therapies for Graves’ ophthalmopathy. An extensive database search of Ovid Medline, Ovid Embase and Cochrane Central Register of Controlled Trials was conducted. …”
    Get full text
    Article
  5. 20325

    Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis by Noriaki Sunaga, Yasuhiko Koga, Yoshimasa Hachisu, Koichi Yamaguchi, Masaki Aikawa, Norimitsu Kasahara, Yosuke Miura, Hiroaki Tsurumaki, Masakiyo Yatomi, Reiko Sakurai, Toshitaka Maeno, Takeshi Hisada

    Published 2022-01-01
    “…Serum NSE levels were associated with organ involvement and were higher in sarcoidosis patients who had been treated with oral corticosteroid (OCS) than in those who had never received OCS therapies; there was a positive association between elevated serum NSE levels and OCS use. …”
    Get full text
    Article
  6. 20326
  7. 20327

    Dynamic analysis of the epidemiology and pathogen distribution of bronchoalveolar lavage fluid in children with severe pulmonary infection: a retrospective study by Muchun Yu, Mingchao Li, Huiqing Sun

    Published 2025-01-01
    “…The early identification of pathogenic bacteria and targeted anti-infective therapies can significantly improve the prognosis of children with severe infections. …”
    Get full text
    Article
  8. 20328

    Melasma management: Unveiling recent breakthroughs through literature analysis by Darshan Kumar R, Richa Sood, Prashant Tiwari

    Published 2025-03-01
    “…Advances in topical formulations, such as combination therapies containing tyrosinase inhibitors, antioxidants, and anti-inflammatory agents, have shown promising results in improving pigmentation and preventing recurrence. …”
    Get full text
    Article
  9. 20329

    Delivering Volumetric Hyperthermia to Head and Neck Cancer Patient-Specific Models Using an Ultrasound Spherical Random Phased Array Transducer by Muhammad Zubair, Imad Uddin, Robert Dickinson, Chris J. Diederich

    Published 2024-12-01
    “…In exploring adjuvant therapies for head and neck cancer, hyperthermia (40–45 °C) has shown efficacy in enhancing chemotherapy and radiation, as well as the delivery of liposomal drugs. …”
    Get full text
    Article
  10. 20330

    Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study by Yujiao Zheng, Fan Yang, Lin Han, Xiaowen Gou, Fengmei Lian, Wenke Liu, Linhua Zhao, Bing Pang, Xiyan Zhao, Xiaolin Tong

    Published 2019-01-01
    “…The modified HGWD was effective in the treatment of moderate and severe pDPN and can thus be offered as a new alternative treatment option for pDPN patients who failed to respond to regular pharmaceutical therapies.…”
    Get full text
    Article
  11. 20331

    IGF-1 impacts neocortical interneuron connectivity in epileptic spasm generation and resolution by Carlos J. Ballester-Rosado, John T. Le, Trang T. Lam, Anne E. Anderson, James D. Frost, Jr., John W. Swann

    Published 2025-01-01
    “…Results point to (1–3)IGF-1 and its analogues as potential novel disease-modifying therapies for this neurodevelopmental disorder.…”
    Get full text
    Article
  12. 20332

    Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular Carcinoma by Hanchuan Tao, Cheng Wang, Chongmei Lu, Ning Ma, Yifan Zhu, Shihai Xuan, Xiaojun Zhou

    Published 2022-01-01
    “…MPV17, as a tumor promoter, could be a new biomarker for LIHC diagnosis and prognosis and probably shed new light on the exploration of LIHC therapies.…”
    Get full text
    Article
  13. 20333

    Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study by Ahmad Golestanifar, Hengameh Khedri, Parisa Noorabadi, Mohammadreza Saberiyan

    Published 2025-03-01
    “…Conclusion: This research provides a foundation for developing targeted therapies and diagnostic biomarkers for KIRC while underscoring the need for experimental validation to confirm these bioinformatics insights.…”
    Get full text
    Article
  14. 20334

    PLUNC downregulates the expression of PD-L1 by inhibiting the interaction of DDX17/β-catenin in nasopharyngeal carcinoma by Ranran Feng, Yilin Guo, Meilin Chen, Ziying Tian, Yijun Liu, Su Jiang, Jieyu Zhou, Qingluan Liu, Xiayu Li, Wei Xiong, Lei Shi, Songqing Fan, Guiyuan Li, Wenling Zhang

    Published 2025-01-01
    “…Background Nasopharyngeal carcinoma (NPC) is characterized by high programmed death-ligand 1 (PD-L1) expression and abundant infiltration of non-malignant lymphocytes, which renders patients potentially suitable candidates for immune checkpoint blockade therapies. Palate, lung, and nasal epithelium clone (PLUNC) inhibit the growth of NPC cells and enhance cellular apoptosis and differentiation. …”
    Get full text
    Article
  15. 20335

    Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts by Xiaoya Liu, Rui Ma, Feng Wei, Maihuan Wang, Yiwei Jiang, Peng Zheng, Zhen Cao

    Published 2025-01-01
    “…Despite advances in adjuvant therapies, bone metastasis remains a challenge for patient survival and quality of life. …”
    Get full text
    Article
  16. 20336

    Factors Associated with the Utilization of Traditional Health Services among People with Non-Communicable Diseases in Indonesia: Findings from a Nationwide Survey by Iwan Abdi Suandana, Putu Ayu Swandewi Astuti, Pande Putu Januraga

    Published 2024-12-01
    “…Of the 127,198 people with NCDs included in the analysis, 38.7% of people with NCDs have ever used traditional health services, with the most common type being those that involve manual therapies. Compared to the reference group, likelihood of higher utilization of the traditional health service was among those aged 45-54 years (adjusted odds ratio (AOR) 1.19; p <0.001), from highest socioeconomic (AOR = 1.13, p <0.001), employed (AOR> 1, p <0.05), married/divorced (AOR> 1, p <0.001), has two type of NCDs (AOR 1.06, p 0.023), knows the existence of the nearest doctor/clinic (AOR 1.36, p <0.001) and hospital (AOR = 1.13, p 0.002) and has very easy access to health facility (AOR 1.34, p <0.001). …”
    Get full text
    Article
  17. 20337

    Development of a patient reported outcome instrument for chronic sialadenitis by Fatemeh Ramazani, Amr Hamour, Caroline C. Jeffery, Vincent Biron, Yaser Alrajhi, Daniel O’Connell, David W. J. Côté

    Published 2022-02-01
    “…Conclusion Clinical application of the novel questionnaire produced by this study will allow for a patient-centered assessment of the patient reported effectiveness of sialendoscopy assisted therapies for management of chronic sialadenitis. Level of evidence Level V. …”
    Get full text
    Article
  18. 20338

    Roles of Copper Transport Systems Members in Breast Cancer by Yichang Chen, Chen Li, Mengxin Li, Bing Han

    Published 2024-12-01
    “…Conclusion By integrating the members of the copper transport system in breast cancer, we offer novel insights for the treatment of breast cancer and copper‐related therapies.…”
    Get full text
    Article
  19. 20339

    Chemokine family significance and prognostic value in colorectal cancer by Yi Ding, Yi Ding, Yi Ding, Yinnan Chen, Yinnan Chen, Yinnan Chen, Siyun Xie, Quanpeng Qiu, Quanpeng Qiu, Xiaolong Guo, Yun Feng, Yun Feng, Hongxia Li, Hongxia Li, Fang Zhu, Yaping Liu, Yaping Liu, Yaping Liu

    Published 2025-01-01
    “…Our new prognostic model could provide important information for the development of targeted therapies for CRC, enhancing personalized treatment approaches andultimately improving survival for CRC patients.…”
    Get full text
    Article
  20. 20340

    CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions by Lei Huang, Yalei Wen, Qin Guo, Caishi Zhang, Xiao Yang, Mei Li, YiXia Liu, Xinying Li, Jiaxin Tang, Xiaofeng Zhou, Qi Qi, Haoxing Zhang, Tongzheng Liu

    Published 2025-01-01
    “…Abstract The aberrant upregulation of Yes-associated protein 1 (YAP1) in a variety of solid cancers contributes to tumor progression and poor clinical outcomes, rendering it an appealing therapeutic target. However, effective therapies to directly target YAP1 remain challenging. …”
    Get full text
    Article